Citric acid price fixing
This article was originally published in The Tan Sheet
Executive Summary
Five suppliers fined $120.5 mil. (€1=$.887) by European Commission for anti-competitive, market-sharing practices from 1991-1997, EC announces Dec. 5. Firms involved are Archer Daniels Midland, Haarmann & Reimer, Cerestar Bioproducts, Hoffmann-La Roche and Jungbunzlauer. Roche incurred largest portion, roughly $56.3 mil. Each firm was charged in proportion to its size, market share, "gravity" and "duration" of infringement, EC notes. Fines for ADM ($35.5 mil.) and Roche were increased because they acted as cartel co-leaders. Roche recently was fined more than $400 mil. by EC as one of eight firms in separate vitamin price-fixing cartel (1"The Tan Sheet" Nov. 26, In Brief)...
You may also be interested in...
Vitamin price fixing
European Commission levies $751.3 mil. fine against eight firms Nov. 21 "for participating in...distinct secret market-sharing and price-fixing cartels affecting vitamin product" from September 1989 to February 1999. Firms charged are Hoffmann-La Roche, BASF, Aventis, Merck KgaA, Solvay Pharmaceuticals, Daiichi Pharmaceutical, Eisai and Takeda Chemical Industries. Since Hoffmann-La Roche "participated in all the cartels," it received the highest fine of $405.9 mil. (1 Euro=$.878). EC decision comes roughly two years after the U.S. Department of Justice levied criminal fines of more than $850 mil. (1"The Tan Sheet" Sept. 13, 1999, p. 4)...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.